FDA expands use of Xarelto to treat, reduce recurrence of blood clots
The US Food and Drug Administration today expanded the approved use of Xarelto (rivaroxaban) to include treating deep vein thrombosis (DVT) or pulmonary embolism (PE), and to reduce the risk of recurrent DVT and PE following initial treatment.
Blocked Blood Flow in Kidney Disease
If your kidneys are damaged, you may start to have health problems in other parts of your body. As rates of kidney disease rise, researchers want to know what these health problems may be.
RA Tied to Deep Vein Blood Clots
Inflammation is a key part of the body's healing process. However, it is also at the root of many health problems, including rheumatoid arthritis and heart and vein disorders.
No Change in Change-of-Life Hormone Warnings
A decade ago, when a woman reached menopause, she likely reached for hormone replacement therapy to calm the symptoms associated with the change in life. Then a large study called the Women's Health Initiative challenged that treatment.
Newer Blood Thinner Gaining Affirmation
Patients with atrial fibrillation, a common heart arrhythmia, have a higher risk of experiencing a stroke or blood clots. Warfarin (Coumadin) has long been the gold standard in treatment. That could be changing.
Spike! But Not Too Hard
Bump, set, spike! With those power moves as volleyball season gets underway, so come the stinging injuries with the slap of the ball.
Blocked Blood Vessels in RA
If you have rheumatoid arthritis, you may be at risk of health problems throughout your body. Even if you've never been hospitalized, you and your doctor need to closely watch for signs of complications.
Antidepressants & Facelift Surgery
Past research suggested that antidepressants might factor into a bleeding risk after surgery. Facelift surgery appeared to be exempt after a recent evaluation.
Heart Diagnostic Test Recalled
A testing system commonly used to diagnose heart problems and other medical conditions has been recalled by the U.S. Food and Drug Administration.
Nano Clot-Buster Targets Blockage
Clot-busting drug tissue plasminogen activator ( tPA ) is the only approved treatment for dissolving blood clots common during stroke, heart attacks or pulmonary embolisms.